Exact Mass: 466.1726
Exact Mass Matches: 466.1726
Found 500 metabolites which its exact mass value is equals to given mass value 466.1726
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Spirapril
Spirapril is an ACE inhibitor antihypertensive drug used to treat hypertension. Like many ACE inhibitors, this is a prodrug which is converted to the active metabolite spiraprilat following oral administration. ACE inhibitors are used primarily in treatment of hypertension and congestive heart failure. C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
Loteprednol etabonate
Clobetasol propionate
Polystachin (flavone)
chloromethyl 17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate
rel-(2R,3S)-3-hydroxymethyl-9-methoxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-2,3,6,7-tetrahydrophenanthro[4,3-b]furan-5,11-diol
6,10,15-trihydro-9(2-hydroxy-2-methylpropyl)-6,6-dimethyldibenzopyrano <2,3-c>xanthen-10-15-quinone|6,10,15-trihydro-9(2-hydroxy-2-methylpropyl)-6,6-dimethyldibenzo[a,i]pyrano [2,3-c]xanthen-10-15-quinone|Tecomaquinone III
3-O-beta-D-glucopyranosyl-8-O-beta-acetyl-1alphaH,5alphaH,6betaH,7alphaH-guai-3(4),10(14),11(13)-triene-15-methyl-6,12-olide|lapsanoside C
3-O-beta-D-glucopyranosyl-8-O-beta-acetyl-1alphaH,5alphaH,6betaH,7alphaH-guai-4(15),10(14),11(13)-triene-6,12-olide|lapsanoside A
2-(4-hydroxyphenyl)ethyl 4,6-O-[(1R,4E)-3-(carboxymethyl)-4-formylhex-4-en-1-ylidene]-beta-Dglucopyranoside|ilexin B
trans-2-{3-O-acetyl-4-O-[(E)-4-hydroxycinnamoyl]-beta-D-glucopyranosyloxy}cyclohexanol
3,3-Bis(hydroxymethyl)-4,4,8,8-tetramethoxy-2,2-binaphthalene-1,1-diol
2-Hydroxy-5-[(2,4-dihydroxy-3,6-dimethylbenzoyl)oxy]-4,6-dimethylbenzoic acid 3-hydroxy-2,5-dimethylphenyl ester
taraxinic acid beta-(6-O-acetyl)-glucopyranosyl ester
Me ester, 4-O-beta-D-glucopyranoside-1, 4-Dihydroxy-3-(3-hydroxy-3-methylbutyl)-2-napthalenecarboxylic acid
(4R,5S,7R,8S)-4-O-(6-acetyl-beta-D-glucopyranosido)-9-oxoguaia-1(10),11(13)-dien-8,12-olide
Ala Asp Phe Asp
(E)-1-(glutathion-S-yl)-N-hydroxy-omega-(methylsulfanyl)hexan-1-imine
N-(beta-D-glucosyl)-(indol-3-yl)acetyl-L-glutamate
2-Naphthalenecarboxylic acid, 4-(D-glucopyranosyloxy)-1-hydroxy-3-(3-hydroxy-3-methylbutyl)-, methyl ester
Loteprednol etabonate
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D018926 - Anti-Allergic Agents
Clobetasol propionate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D000893 - Anti-Inflammatory Agents CONFIDENCE standard compound; INTERNAL_ID 2837
Ala Cys His His
Ala Asp Asp Phe
Ala Asp Met Met
Ala Phe Asp Asp
Ala His Cys His
Ala His His Cys
Ala Met Asp Met
Ala Met Met Asp
Cys Ala His His
Cys Cys Glu Ile
Cys Cys Glu Leu
Cys Cys Ile Glu
Cys Cys Lys Asn
Cys Cys Leu Glu
Cys Cys Asn Lys
Cys Asp Met Val
Cys Asp Val Met
Cys Glu Cys Ile
Cys Glu Cys Leu
Cys Glu Ile Cys
Cys Glu Leu Cys
Cys Phe Pro Thr
Cys Phe Thr Pro
Cys His Ala His
Cys His His Ala
Cys Ile Cys Glu
Cys Ile Glu Cys
Cys Ile Met Thr
Cys Ile Thr Met
Cys Lys Cys Asn
Cys Lys Asn Cys
Cys Leu Cys Glu
Cys Leu Glu Cys
Cys Leu Met Thr
Cys Leu Thr Met
Cys Met Asp Val
Cys Met Ile Thr
Cys Met Leu Thr
Cys Met Thr Ile
Cys Met Thr Leu
Cys Met Val Asp
Cys Asn Cys Lys
Cys Asn Lys Cys
Cys Pro Phe Thr
Cys Pro Thr Phe
Cys Thr Phe Pro
Cys Thr Ile Met
Cys Thr Leu Met
Cys Thr Met Ile
Cys Thr Met Leu
Cys Thr Pro Phe
Cys Val Asp Met
Cys Val Met Asp
Asp Ala Asp Phe
Asp Ala Phe Asp
Asp Ala Met Met
Asp Cys Met Val
Asp Cys Val Met
Asp Asp Ala Phe
Asp Asp Phe Ala
Asp Glu Phe Gly
Asp Glu Gly Phe
Asp Phe Ala Asp
Asp Phe Asp Ala
Asp Phe Glu Gly
Asp Phe Gly Glu
Asp Gly Glu Phe
Asp Gly Phe Glu
Asp Met Ala Met
Asp Met Cys Val
Asp Met Met Ala
Asp Met Thr Thr
Asp Met Val Cys
Asp Thr Met Thr
Asp Thr Thr Met
Asp Val Cys Met
Asp Val Met Cys
Glu Cys Cys Ile
Glu Cys Cys Leu
Glu Cys Ile Cys
Glu Cys Leu Cys
Glu Asp Phe Gly
Glu Asp Gly Phe
Glu Phe Asp Gly
Glu Phe Gly Asp
Glu Gly Asp Phe
Glu Gly Phe Asp
Glu Gly Met Met
Glu Ile Cys Cys
Glu Leu Cys Cys
Glu Met Gly Met
Glu Met Met Gly
Glu Met Ser Thr
Glu Met Thr Ser
Glu Ser Met Thr
Glu Ser Thr Met
Glu Thr Met Ser
Glu Thr Ser Met
Phe Ala Asp Asp
Phe Cys Pro Thr
Phe Cys Thr Pro
Phe Asp Ala Asp
Phe Asp Asp Ala
Phe Asp Glu Gly
Phe Asp Gly Glu
Phe Glu Asp Gly
Phe Glu Gly Asp
Phe Gly Asp Glu
Phe Gly Glu Asp
Phe Pro Cys Thr
Phe Pro Thr Cys
Phe Thr Cys Pro
Phe Thr Pro Cys
Gly Asp Glu Phe
Gly Asp Phe Glu
Gly Glu Asp Phe
Gly Glu Phe Asp
Gly Glu Met Met
Gly Phe Asp Glu
Gly Phe Glu Asp
Gly Met Glu Met
Gly Met Met Glu
Gly Met Pro Tyr
Gly Met Tyr Pro
Gly Asn Asn Tyr
Gly Asn Tyr Asn
Gly Pro Met Tyr
Gly Pro Tyr Met
Gly Tyr Met Pro
Gly Tyr Asn Asn
Gly Tyr Pro Met
His Ala Cys His
His Ala His Cys
His Cys Ala His
His Cys His Ala
His His Ala Cys
His His Cys Ala
Ile Cys Cys Glu
Ile Cys Glu Cys
Ile Cys Met Thr
Ile Cys Thr Met
Ile Glu Cys Cys
Ile Met Cys Thr
Ile Met Thr Cys
Ile Thr Cys Met
Ile Thr Met Cys
Lys Cys Cys Asn
Lys Cys Asn Cys
Lys Asn Cys Cys
Leu Cys Cys Glu
Leu Cys Glu Cys
Leu Cys Met Thr
Leu Cys Thr Met
Leu Glu Cys Cys
Leu Met Cys Thr
Leu Met Thr Cys
Leu Thr Cys Met
Leu Thr Met Cys
Met Ala Asp Met
Met Ala Met Asp
Met Cys Asp Val
Met Cys Ile Thr
Met Cys Leu Thr
Met Cys Thr Ile
Met Cys Thr Leu
Met Cys Val Asp
Met Asp Ala Met
Met Asp Cys Val
Met Asp Met Ala
Met Asp Thr Thr
Met Asp Val Cys
Met Glu Gly Met
Met Glu Met Gly
Met Glu Ser Thr
Met Glu Thr Ser
Met Gly Glu Met
Met Gly Met Glu
Met Gly Pro Tyr
Met Gly Tyr Pro
Met Ile Cys Thr
Met Ile Thr Cys
Met Leu Cys Thr
Met Leu Thr Cys
Met Met Ala Asp
Met Met Asp Ala
Met Met Glu Gly
Met Met Gly Glu
Met Met Ser Val
Met Met Val Ser
Met Pro Gly Tyr
Met Pro Tyr Gly
Met Ser Glu Thr
Met Ser Met Val
Met Ser Thr Glu
Met Ser Val Met
Met Thr Cys Ile
Met Thr Cys Leu
Met Thr Asp Thr
Met Thr Glu Ser
Met Thr Ile Cys
Met Thr Leu Cys
Met Thr Ser Glu
Met Thr Thr Asp
Met Val Cys Asp
Met Val Asp Cys
Met Val Met Ser
Met Val Ser Met
Met Tyr Gly Pro
Met Tyr Pro Gly
Asn Cys Cys Lys
Asn Cys Lys Cys
Asn Gly Asn Tyr
Asn Gly Tyr Asn
Asn Lys Cys Cys
Asn Asn Gly Tyr
Asn Asn Tyr Gly
Asn Tyr Gly Asn
Asn Tyr Asn Gly
Pro Cys Phe Thr
Pro Cys Thr Phe
Pro Phe Cys Thr
Pro Phe Thr Cys
Pro Gly Met Tyr
Pro Gly Tyr Met
Pro Met Gly Tyr
Pro Met Tyr Gly
Pro Thr Cys Phe
Pro Thr Phe Cys
Pro Tyr Gly Met
Pro Tyr Met Gly
Ser Glu Met Thr
Ser Glu Thr Met
Ser Met Glu Thr
Ser Met Met Val
Ser Met Thr Glu
Ser Met Val Met
Ser Thr Glu Met
Ser Thr Met Glu
Ser Val Met Met
Thr Cys Phe Pro
Thr Cys Ile Met
Thr Cys Leu Met
Thr Cys Met Ile
Thr Cys Met Leu
Thr Cys Pro Phe
Thr Asp Met Thr
Thr Asp Thr Met
Thr Glu Met Ser
Thr Glu Ser Met
Thr Phe Cys Pro
Thr Phe Pro Cys
Thr Ile Cys Met
Thr Ile Met Cys
Thr Leu Cys Met
Thr Leu Met Cys
Thr Met Cys Ile
Thr Met Cys Leu
Thr Met Asp Thr
Thr Met Glu Ser
Thr Met Ile Cys
Thr Met Leu Cys
Thr Met Ser Glu
Thr Met Thr Asp
Thr Pro Cys Phe
Thr Pro Phe Cys
Thr Ser Glu Met
Thr Ser Met Glu
Thr Thr Asp Met
Thr Thr Met Asp
Val Cys Asp Met
Val Cys Met Asp
Val Asp Cys Met
Val Asp Met Cys
Val Met Cys Asp
Val Met Asp Cys
Val Met Met Ser
Val Met Ser Met
Val Ser Met Met
Tyr Gly Met Pro
Tyr Gly Asn Asn
Tyr Gly Pro Met
Tyr Met Gly Pro
Tyr Met Pro Gly
Tyr Asn Gly Asn
Tyr Asn Asn Gly
Tyr Pro Gly Met
Tyr Pro Met Gly
Spirapril
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09A - Ace inhibitors, plain > C09AA - Ace inhibitors, plain D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
[3-[6-methoxy-1,3-dioxo-1H-benz[de]-2(3H)-isoquinolyl]-2,2-dimethylpropyl]trimethylammonium methyl sulphate
4-methylumbelliferyl phosphate, bis(2-amino-2-methyl-1,3-propanediol) salt
Thymol blue
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D010635 - Phenolphthaleins
Diphenylmethyl (2R)-3-methyl-2-[3-(4-methylphenyl)-7-oxo-4-oxa-2,6-diazabicyclo[3.2.0]hept-2-en-6-yl]-3-butenoate
Rogaratinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C164035 - FGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C155727 - FGFR Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
Platensimycin B2
A polycyclic cage that is platensimycin with a 1,3-oxazinane ring fused onto the aromatic ring. It is isolated from Streptomyces platensis.
Ethyl 4-((methyl(3-(pyridin-4-yl)benzyl)carbamoyl)oxy)-[1,1-biphenyl]-4-carboxylate
N-[4-(Trifluoromethyl)phenyl]-N-[1-[5-(Trifluoromethyl)pyridin-2-Yl]piperidin-4-Yl]pyridin-3-Amine
[(2R,2aS,7R,7aS,7bR)-2,2a,7-trihydroxy-6,6,7b-trimethyl-1,2,4a,5,7,7a-hexahydrocyclobuta[e]inden-3-yl]methyl 3-chloro-6-hydroxy-4-methoxy-2-methylbenzoate
Phosphonooxy-[(10e)-3,7,11,15-Tetramethylhexadeca-2,6,10,14-Tetraenyl]sulfanyl-Phosphinic Acid
(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-[(E)-N-hydroxy-C-(5-methylsulfanylpentyl)carbonimidoyl]sulfanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
N-[[1-(beta-D-Glucopyranosyl)-1H-indole-3-yl]acetyl]-L-glutamic acid
6-(3-cyclopentyloxy-4-methoxyphenyl)-3-(2,5-dimethoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
N-[(4-chlorophenyl)methyl]-2-[(1S,4S,6E,12R)-3,10-dioxo-2-oxa-11-azatricyclo[10.7.0.013,18]nonadeca-6,13,15,17-tetraen-4-yl]acetamide
2,3-bis(2-furanyl)-N-[4-(4-morpholinyl)phenyl]-6-quinoxalinecarboxamide
2-(4-benzoylphenoxy)-N-[4-(propan-2-ylsulfamoyl)phenyl]propanamide
N-[2-(2,5-dimethoxyphenyl)ethyl]-4-[(4-fluorophenyl)methyl]-2,3-dihydro-1,4-benzothiazine-6-carboxamide
N-[2-[[2-(cyclopentylamino)-2-oxo-1-pyridin-4-ylethyl]-(thiophen-2-ylmethyl)amino]-2-oxoethyl]-2-furancarboxamide
2-(1,3-dimethyl-2,6-dioxo-9-purinyl)-N-[2-(4-morpholinyl)-5-(trifluoromethyl)phenyl]acetamide
[4-[Bis(4-methoxyphenyl)methyl]-1-piperazinyl]-(5-methyl-4-nitro-3-isoxazolyl)methanone
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[[4-(trifluoromethyl)phenyl]carbamoylamino]ethyl]oxan-3-yl]pyridine-3-carboxamide
N-[(3-fluorophenyl)methyl]-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]oxan-2-yl]acetamide
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[[4-(trifluoromethyl)phenyl]carbamoylamino]ethyl]oxan-3-yl]pyridine-3-carboxamide
N-[(3-fluorophenyl)methyl]-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]oxan-2-yl]acetamide
N-[(3-fluorophenyl)methyl]-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(3-fluorophenyl)methyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide
N-[(3-fluorophenyl)methyl]-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(3-fluorophenyl)methyl]-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(2-fluorophenyl)methyl]-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(2-fluorophenyl)methyl]-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(2-fluorophenyl)methyl]-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
[(3aS,4R,9bS)-8-(2-fluorophenyl)-5-methyl-1-(3-methylphenyl)sulfonyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide
N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]ethyl]-3-oxanyl]-3-pyridinecarboxamide
N-[(3-fluorophenyl)methyl]-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(3-fluorophenyl)methyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(2-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(2-fluorophenyl)methyl]-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(2-fluorophenyl)methyl]-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(2-fluorophenyl)methyl]-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(2-fluorophenyl)methyl]-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(2-fluorophenyl)methyl]-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[(4-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
[(3aR,4S,9bR)-8-(2-fluorophenyl)-5-methyl-1-(3-methylphenyl)sulfonyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aR,4R,9bR)-8-(2-fluorophenyl)-5-methyl-1-(3-methylphenyl)sulfonyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
[(3aS,4S,9bS)-8-(2-fluorophenyl)-5-methyl-1-(3-methylphenyl)sulfonyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-4-yl]methanol
5-(2-Fluorophenyl)-4-(2-methyl-2,3-dihydro-1-benzofuran-5-carbonyl)-1-(2-morpholin-4-ylethyl)pyrrolidine-2,3-dione
4-(2,8-Dimethylimidazo[1,2-a]pyridine-3-carbonyl)-1-(2-morpholin-4-ylethyl)-5-thiophen-2-ylpyrrolidine-2,3-dione
L-gamma-glutamyl-S-[N-hydroxy-6-(methylsulfanyl)hexanimidoyl]-L-cysteinylglycine
[(8S,9R,10S,11S,13S,14S,16S)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
[(8S,9S,10S,11R,13S,14S,16S,17S)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
chloromethyl (8S,9R,10R,11R,13S,14S,17S)-17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate
S-(6-methylthiohexylhydroximoyl)glutathione
An S-substituted glutathione in which the thiol hydrogen of glutathoine has been replaced by a 6-methylthiohexylhydroximoyl group.
(3ar,4r,6ar,8s,9ar,9br)-3,6,9-trimethylidene-2-oxo-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-4-yl acetate
3,6,9-trimethylidene-2-oxo-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-4-yl acetate
methyl (6as,8r,9r,9as)-5-chloro-8-hydroxy-8-[(2r,3r)-3-hydroxybutan-2-yl]-6a-methyl-3-[(1e,3s)-3-methylpent-1-en-1-yl]-6-oxo-9h,9ah-furo[2,3-h]isochromene-9-carboxylate
(2r,2as,4ar,7ar,7br)-2a,4a-dihydroxy-3-(hydroxymethyl)-6,6,7b-trimethyl-1h,2h,5h,7h,7ah-cyclobuta[e]inden-2-yl 3-chloro-6-hydroxy-4-methoxy-2-methylbenzoate
18-methoxy-13,14-dimethyl-19,20-dioxo-3,6,8-trioxapentacyclo[9.9.1.0¹,¹⁶.0⁴,²¹.0⁵,⁹]henicosa-4(21),5(9),10,15,17-pentaen-12-yl 2-methylbut-2-enoate
6-[(acetyloxy)methyl]-3,4,5-trihydroxyoxan-2-yl 10-methyl-3-methylidene-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
(2r,3r,4r,5r,6r)-4-(acetyloxy)-5-hydroxy-6-{[(1s,2s)-2-hydroxycyclohexyl]oxy}-2-(hydroxymethyl)oxan-3-yl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
(26s)-26-(2-hydroxy-2-methylpropyl)-5,5-dimethyl-6,15-dioxahexacyclo[12.12.0.0²,⁷.0⁸,¹³.0¹⁶,²⁵.0¹⁸,²³]hexacosa-1(14),2(7),3,8,10,12,16(25),18,20,22-decaene-17,24-dione
4-({4'-hydroxy-3-[2-(4-hydroxyphenyl)ethynyl]-[1,1'-biphenyl]-2-yl}(phenyl)methylidene)cyclohexa-2,5-dien-1-one
3-hydroxy-2,5-dimethylphenyl 3-(2,4-dihydroxy-3,6-dimethylbenzoyloxy)-6-hydroxy-2,4-dimethylbenzoate
(2r*,3s*)-3-hydroxymethyl-9-methoxy-2-(4'-hydroxy-3',5'-dimethoxyphenyl)-2,3,6,7-tetrahydrophenanthro[4,3-b]furan-5,11-diol
{"Ingredient_id": "HBIN006472","Ingredient_name": "(2r*,3s*)-3-hydroxymethyl-9-methoxy-2-(4'-hydroxy-3',5'-dimethoxyphenyl)-2,3,6,7-tetrahydrophenanthro[4,3-b]furan-5,11-diol","Alias": "NA","Ingredient_formula": "C26H26O8","Ingredient_Smile": "COC1=CC(=C2C(=C1)CCC3=C(C=C4C(C(OC4=C32)C5=CC(=C(C(=C5)OC)O)OC)CO)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10503","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}